Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03694327 · ClinicalTrials.gov registry record · NA

Innovative Digital Therapeutic for Smoking Cessation

A NA study of Smoking Cessation and Tobacco Use Disorder, sponsored by My Digital Study.

Completed
Registry status
NA
Development phase
158
Enrollment target
1
Study location

NCT03694327 is a NA study of Smoking Cessation and Tobacco Use Disorder that has completed, run by My Digital Study. The registered enrollment target is 158 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03694327, a NA study of Smoking Cessation and Tobacco Use Disorder, has completed, sponsored by My Digital Study.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target
1
Study location

Study Summary

This study is comparing the efficacy of two smoking cessation apps.

Conditions Studied

Smoking Cessation Tobacco Use Disorder Tobacco Smoking Tobacco Dependence Substance Use Disorder Drug Addiction Nicotine Addiction Drug Dependence

Interventions

  • DEVICE CT-101-M
  • DEVICE QuitGuide

Study Locations (1)

New York

  • My Digital Study - New York

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2018-10-24
Est. Completion 2019-03-14
Phase NA

Sponsor

My Digital Study

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03694327

The ClinicalTrials.gov registry entry for NCT03694327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (67% lower). The listed sponsor is My Digital Study, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which CT-101-M is the first listed.

NCT03694327 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03694327 about?

NCT03694327 is a clinical study titled "Innovative Digital Therapeutic for Smoking Cessation". This study is comparing the efficacy of two smoking cessation apps.

What is the current status of trial NCT03694327?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2018-10-24. Estimated completion is 2019-03-14.

What conditions does trial NCT03694327 study?

This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence, Substance Use Disorder.

What interventions are being tested in trial NCT03694327?

The interventions under investigation include: CT-101-M (DEVICE), QuitGuide (DEVICE).

Who is sponsoring clinical trial NCT03694327?

This trial is sponsored by My Digital Study, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03694327 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Smoking Cessation

All registered trials for this condition

Tobacco Use Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.